C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/00 (2006.01) A61K 31/47 (2006.01) C07D 215/00 (2006.01) C07D 217/00 (2006.01)
Patent
CA 2589565
The present invention relates to inhibitors of 11-.beta. hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression of activity of 11-.beta. hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess.
L'invention porte sur des inhibiteurs de la 11-ß hydroxyle stéroïde déshydrogénase de type 1, antagonistes du récepteur minéralocorticoïde (MR), et sur leurs préparations pharmaceutiques. Lesdits composés peuvent servir au traitement de diverses maladies associées à l'expression de l'activité de la 11-ß hydroxyle stéroïde déshydrogénase de type 1 et/ou associées à un excès d'aldostérone.
Agrios Konstantinos
Metcalf Brian
Yao Wenqing
Zhang Colin
Zhuo Jincong
Incyte Corporation
Smart & Biggar
LandOfFree
Amido compounds and their use as pharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amido compounds and their use as pharmaceuticals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amido compounds and their use as pharmaceuticals will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1567951